Michael Kujak

NXThera, Inc. provides technology platform to treat endourological conditions. It develops medical devices to treat patients suffering from urologic conditions, such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. The company was founded by John H. Shadduck and Michael Hoey in 2008 and is headquartered in Maple Grove, MN.

NXThera, Inc. provides technology platform to treat endourological conditions. It develops medical devices to treat patients suffering from urologic conditions, such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. The company was founded by John H. Shadduck and Michael Hoey in 2008 and is headquartered in Maple Grove, MN.

Francis Medical, Inc. develops an innovative and patented vapor ablation therapy to treat a variety of endourological cancers, beginning with prostate cancer. The company was founded by Michael F. Hoey and is headquartered in Maple Grove, MN.

Francis Medical, Inc. develops an innovative and patented vapor ablation therapy to treat a variety of endourological cancers, beginning with prostate cancer. The company was founded by Michael F. Hoey and is headquartered in Maple Grove, MN.

Francis Medical, Inc. develops an innovative and patented vapor ablation therapy to treat a variety of endourological cancers, beginning with prostate cancer. The company was founded by Michael F. Hoey and is headquartered in Maple Grove, MN.

NXThera, Inc. provides technology platform to treat endourological conditions. It develops medical devices to treat patients suffering from urologic conditions, such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. The company was founded by John H. Shadduck and Michael Hoey in 2008 and is headquartered in Maple Grove, MN.

Uro Medical Corp. is a medical device company that develops, manufactures, and commercializes wirelessly powered, microtechnology neurostimulators for urological solutions. The private company is based in Boca Raton, FL, and has subsidiaries in the United States. The company aims to provide patients with convenient, safe, minimally invasive, and highly cost-effective solutions that can be easily incorporated into their daily lives. Uro Medical's patented platform for neuromodulation aims to become the standard of care, increasing accessibility for patients worldwide while lowering the economic impact of urology care management. The company was founded by Laura H. Tyler.

Uro Medical Corp. is a medical device company that develops, manufactures, and commercializes wirelessly powered, microtechnology neurostimulators for urological solutions. The private company is based in Boca Raton, FL, and has subsidiaries in the United States. The company aims to provide patients with convenient, safe, minimally invasive, and highly cost-effective solutions that can be easily incorporated into their daily lives. Uro Medical's patented platform for neuromodulation aims to become the standard of care, increasing accessibility for patients worldwide while lowering the economic impact of urology care management. The company was founded by Laura H. Tyler.

Uro Medical Corp. is a medical device company that develops, manufactures, and commercializes wirelessly powered, microtechnology neurostimulators for urological solutions. The private company is based in Boca Raton, FL, and has subsidiaries in the United States. The company aims to provide patients with convenient, safe, minimally invasive, and highly cost-effective solutions that can be easily incorporated into their daily lives. Uro Medical's patented platform for neuromodulation aims to become the standard of care, increasing accessibility for patients worldwide while lowering the economic impact of urology care management. The company was founded by Laura H. Tyler.

Uro Medical Corp. is a medical device company that develops, manufactures, and commercializes wirelessly powered, microtechnology neurostimulators for urological solutions. The private company is based in Boca Raton, FL, and has subsidiaries in the United States. The company aims to provide patients with convenient, safe, minimally invasive, and highly cost-effective solutions that can be easily incorporated into their daily lives. Uro Medical's patented platform for neuromodulation aims to become the standard of care, increasing accessibility for patients worldwide while lowering the economic impact of urology care management. The company was founded by Laura H. Tyler.